Nanjing Immunophage Biotech Co., Ltd

This early-stage study tested a new oral drug, IPG1094, in 76 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects. The goal was to gather initial safety data, not to trea…

This early-stage study tested a new oral drug, IPG11406, in 66 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo. This research does not treat any disease but is a necessary first step before testing the drug in …